A model for endosymbiosis: Interaction between Tetrahymena pyriformis and Escherichia coliSIEGMUND, Lisa; BURMESTER, Anke; FISCHER, Martin S et al.European journal of protistology (Print). 2013, Vol 49, Num 4, pp 552-563, issn 0932-4739, 12 p.Article

AMINOGLYCOSIDE ANTIBIOTICS: OXIDATIVE DEGRADATIONS LEADING TO NOVEL BIOCHEMICAL PROBES AND SYNTHETIC INTERMEDIATESHANESSIAN S; TAKAMOTO T; MASSE R et al.1975; J. ANTIBIOT.; JAP.; DA. 1975; VOL. 28; NO 10; PP. 835-836; BIBL. 16 REF.Article

Inhibition of antiassociation activity of translation initiation factor 3 by paromomycin∇HIROKAWA, Go; KAJI, Hideko; KAJI, Akira et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 1, pp 175-180, issn 0066-4804, 6 p.Article

The effects of paromomycin on the fidelity of translation in a yeast cell-free systemTUITE, M. F; MCLAUGHLIN, C. S.Biochimica et biophysica acta. 1984, Vol 783, Num 2, pp 166-170, issn 0006-3002Article

Production of hevea brasiliensis transgenic embryogenic callus lines by Agrobacterium tumefaciens: roles of calciumMONTORO, P; RATTANA, W; PUJADE-RENAUD, V et al.Plant cell reports (Print). 2003, Vol 21, Num 11, pp 1095-1102, issn 0721-7714, 8 p.Article

SEMISYNTHETIC AMINOGLYCOSIDE ANTIBIOTICS. I. NEW REACTIONS OF PAROMOMYCIN AND SYNTHESIS OF ITS 2'-N-ETHYLDERIVATIVE.CASSINELLI G; FRANCESCHI G; DI COLO G et al.1978; J. ANTIBIOT.; JAP.; DA. 1978; VOL. 31; NO 4; PP. 379-381; BIBL. 9 REF.Article

Paromomycin and neomycin B derived cationic lipids: Synthesis and transfection studiesMEVEL, Mathieu; SAINLOS, Matthieu; CHATIN, Benoît et al.Journal of controlled release. 2012, Vol 158, Num 3, pp 461-469, issn 0168-3659, 9 p.Article

Efficacy of S-adenosylhomocysteine hydrolase inhibitors, D-eritadenine and (S)-DHPA, against the growth of Cryptosporidium parvum in vitroCTRNACTA, Vlasta; FRITZLER, Jason M; SURINOVA, Mária et al.Experimental parasitology. 2010, Vol 126, Num 2, pp 113-116, issn 0014-4894, 4 p.Article

Treatment of Dientamoeba fragilis infection with paromomycinVANDENBERG, Olivier; SOUAYAH, Hichem; MOUCHET, Francoise et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 1, pp 88-90, issn 0891-3668, 3 p.Article

Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensisMUSSI, Samuel Vidal; FERNANDES, Ana Paula; FERREIRA, Lucas Antonio Miranda et al.Parasitology research (1987). 2007, Vol 100, Num 6, pp 1221-1226, issn 0932-0113, 6 p.Article

Neomycin and paromomycin inhibit 30S ribosomal subunit assembly in Staphylococcus aureusMEHTA, Roopal; CHAMPNEY, W. Scott.Current microbiology (Print). 2003, Vol 47, Num 3, pp 237-243, issn 0343-8651, 7 p.Article

Sensitivity of spermidine-deficient Saccharomyces cerevisiae to paromomycinBALASUNDARAM, D; TABOR, C. W; TABOR, H et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 5, pp 1314-1316, issn 0066-4804Article

AMINOGLYCOSIDE ANTIBIOTICS: CHEMICAL TRANSFORMATION OF PAROMOMYCIN INTO A BIOACTIVE PSEUDOTRISACCHARIDETAKAMOTO T; HANESSIAN S.1974; TETRAHEDRON LETTERS; G.B.; DA. 1974; NO 46; PP. 4009-4012; BIBL. 10 REF.Article

Treatment and prevention of cryptosporidiosis: what options are there for a country like Zambia?KELLY, Paul.Parasitology (London. Print). 2011, Vol 138, pp 1488-1491, issn 0031-1820, 4 p., 12Article

ParomomycinDAVIDSON, Robert N; DEN BOER, Margriet; RITMEIJER, Koert et al.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009, Vol 103, Num 7, pp 653-660, issn 0035-9203, 8 p.Article

6-Hydroxy to 6'-amino tethered ring-to-ring macrocyclic aminoglycosides as probes for APH(3')-IIIa kinaseHANESSIAN, Stephen; SZYCHOWSKI, Janek; CAMPOS-REALES PINEDA, Natalhie B et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 11, pp 3221-3225, issn 0960-894X, 5 p.Article

Treatment of cryptosporidiosis with paromomycin : a report of five casesARMITAGE, K; FLANIGAN, T; CAREY, J et al.Archives of internal medicine (1960). 1992, Vol 152, Num 12, pp 2497-2499, issn 0003-9926Article

IL TRATTAMENTO DELLE FLOGOSI BRONCOPNEUMONICHE ACUTE CON UN ANTIBIOTICO OLIGOSACCARIDICO: LA AMMINOSIDINA. = LE TRAITEMENT DES INFECTIONS BRONCHOPULMONAIRES AIGUES AVEC UN ANTIBIOTIQUE OLIGOSIDIQUE: L'AMMINOSIDINEBONOMO E; LANZANI PL; RASCHI P et al.1976; MINERVA PNEUMOL.; ITAL.; DA. 1976; VOL. 15; NO 1; PP. 35-42; ABS. ANGL.; BIBL. 10 REF.Article

ZUR PHYSIOLOGIE UND BIOCHEMIE DER STREPTOMYCETEN. II. CHEMISCHER ABBAU UND ISOLIERUNG DER ABBAUPRODUKTE VON PAROMOMYCIN = PHYSIOLOGIE ET BIOCHIMIE DES STREPTOMYCETES. II. DEGRADATION CHIMIQUE DE LA PAROMOMYCINE ET ISOLEMENT DES PRODUITS DE DEGRADATIONLIEBERMANN B; KOSTER H; REUTER G et al.1975; PHARMAZIE; DTSCH.; DA. 1975; VOL. 30; NO 12; PP. 796-798; BIBL. 12 REF.Article

Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasisSANE, Shraddha A; SHAKYA, Nishi; GUPTA, Suman et al.Experimental parasitology. 2011, Vol 127, Num 2, pp 376-381, issn 0014-4894, 6 p.Article

Leishmania major : In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator ImiquimodEL-ON, Joseph; BAZARSKY, Elina; SNEIR, Rachella et al.Experimental parasitology. 2007, Vol 116, Num 2, pp 156-162, issn 0014-4894, 7 p.Article

Swapped green algal promoters : aphVIII-based gene constructs with Chlamydomonas flanking sequences work as dominant selectable markers in Volvox and vice versaHALLMANN, A; WODNIOK, S.Plant cell reports (Print). 2006, Vol 25, Num 6, pp 582-591, issn 0721-7714, 10 p.Article

Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c miceBAVARSAD, Neda; BAZZAZ, Bibi Sedigheh Fazly; KHAMESIPOUR, Ali et al.Acta tropica. 2012, Vol 124, Num 1, pp 33-41, issn 0001-706X, 9 p.Article

Topische Therapie einer persistierenden kutanen Leishmaniase mit Paromomycin = Topical treatment of persistent cutaneous leishmaniasis with paromomycinFLAIG, M. J; RUPEC, J; RUZICKA, T et al.Hautarzt. 2007, Vol 58, Num 8, pp 689-692, issn 0017-8470, 4 p.Article

Mise au point sur le traitement de la cryptosporidiose : intérêt du nitazoxanide = Focus on cryptosporidiosis treatment : place of nitazoxanidDIVOUX, E; SZAJNER, S; LE MOAL, G et al.Journal de pharmacie clinique (Paris). 2006, Vol 25, Num 4, pp 197-205, issn 0291-1981, 9 p.Article